Conference Paper
BibTex RIS Cite
Year 2012, Volume: 29 Issue: 4, 272 - 275, 27.12.2012
https://doi.org/10.5835/jecm.omu.29.04.004

Abstract

References

  • Bouzas, E.A., Karadimas, P., Pournaras, C.J., 2002. Central serous chorioretinopathy and glucocorticoids. Surv. Ophthalmol. 47, 431-438.
  • Burumcek, E., Mudun, A., Karakocoglu, S., Arslan, M.O., 1997. Laser photocoagulation for persistent central serous retinopathy: results of long term follow-up. Ophthalmology. 104, 616-622.
  • Cardillo Piccolino, F., Eandi, C.M., Ventre, L., Rigault de la Longrais, R.C., Grignolo, F.M., 2003. Photodynamic therapy for chronic central serous chorioretinopathy. Retina. 23, 752-763.
  • Castro-Correia, J., Coutinho, M.F., Rosas, V., Maia, J., 1992. Long-term follow-up of central serous retinopathy in 150 patients. Doc. Ophthalmol. 81, 379-386.
  • Chrousos, G.P., Gold, P.W., 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267, 1244-1252.
  • Costa, R.A., Calucci, D., Skaf, M., Cardillo, J.A., Castro, J.C., Melo, L.A.Jr, Martins, M.C., Kaiser, P.K., 2004. Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest. Ophthalmol. Vis. Sci. 45, 2399-2406.
  • Ficker, L., Vafidis, G., While, A., Leaver, P., 1988. Long-term follow up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br. J. Ophthalmol. 72, 829-834.
  • Friedman, M., Byers, S.O., Rosenman, R.H., Franklin, R. E., 1970. Coronary-prone individuals (Type-A behavior pattern). Some biochemical characteristics. JAMA. 212, 1030-1037.
  • Gass, J.D.M., 1977. Photocoagulation treatment of idiopathic central serous chorioretinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 83, 456-467.
  • Gonzalez, C., 1992. Decollements sereux retiniens. J. Fr. Ophthalmol. 15, 529-536. Harrington, D.O., 1948. Psychosomatic interrelationship inophthalmology. Am. J. Ophthalmol. 31, 1241-1251.
  • Hee, M.R., Puliafito, C.A., Wong, C., 1995. Optical coherence tomography of central serous chorioretinopathy. Am. J. Ophthalmol. 120, 65- 74.
  • Huang, W.C., Chen, W.L., Tsai, Y.Y., Chiang, C.C., Lin, J.M., 2009. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eye. 23, 488-489.
  • Maumenee, A.E., 1965. Macular diseases: clinical manifestations. Trans. Am. Acad. Ophthalmol. 69, 605-613.
  • Meyerle, C.B., Freund, K.B., Bhatnagar, P., Shah, V., Yannuzzi, L.A., 2007. Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina, 27, 943-946.
  • Nagayoski, K., 1971. Experimental study of chorioretinopathy by intravenous injection of adrenaline. Acta Soc. Ophthalmol. Jpn. 75, 1720- 1727.
  • Polak, B.C.P., Baarsma, G.S., Snyers, B., 1995. Diffuse retinal pigment epithelyopathy complicating systemic corticosteroid treatment. Br. J. Ophthalmol. 79, 922-925.
  • Pomerleau, O.F., Pomerleau, C.S., 1990. Cortisol response to a psychological stressor and/or nicotine. Pharmacol. Biochem. Behav. 36, 211- 213.
  • Prunte, C., Flammer, J., 1996. Choroidal capillary and venous congestion in central serous choroidopathy. Am. J. Ophthalmol. 121, 26-34.
  • Quillen, D.A., Gass, D.M., Brod, R.D., Gardner, T.W., Blankenship, G.W., Gottlieb, J.L., 1996. Central serous chorioretinopathy in women. Ophthalmology. 103, 72-79.
  • Robertson, D.M., illstrupp, D., 1983. Direct, indirect and sham laser treatment in the management of central serous choroidopathy. Am. J. Ophthalmol. 95, 457-466.
  • Shukla, D., Kolluru, C., Vignesh, T.P., Karthikprakash, S., Kim, R., 2006. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy. Eye. 22, 100-106.
  • Spahn, C., Wiek, J., Burger, T., Hansen, L., 2003. Psychosomatic aspects in patients with central cerous chorioretinopathy. Br. J. Ophthalmol. 87, 704-708.
  • Von Graefe, A., 1866. Kurzere abhandlungen, notizen und casaistische mitheilugnen vermischten inhalts: VI. Ueber zentrale recidivirende retinitis. Graefes Arch. Clin. Ophthalmol. 12, 211-215.
  • Yannuzzi, L.A., 1986. Type A behavior and central serous chorioretinopathy. Trans. Am. Ophthalmol. Soc. 84, 799-845.
  • Yannuzzi, L.A., Slakter, J.S., Kaufman, S.R., Gupta, K., 1992. Laser treatment of diffuse retinal pigment epitheliopathy. Eur. J. Ophthalmol. 2, 103-114.
  • Yanoff, M., Duker, J.S., 2004. Ophtalmology: 2nd edition, St. Louis: Mosby, p.p. 938-941.
  • Zeligs, M.A., 1947. Central angiospastic retinopathy: a psychosomatic study of the occurrence in military personnel. Psychosom. Med. 9, 110- 117.

Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri

Year 2012, Volume: 29 Issue: 4, 272 - 275, 27.12.2012
https://doi.org/10.5835/jecm.omu.29.04.004

Abstract

Bu çalışmada santral seröz koryoretinopati (SSR)’li olgularda doğal seyir sonuçlarının ve predispozan faktörlerin bildirilmesi amaçlanmıştır. Primer SSR tanısı konulan ve 6 aylık takip boyunca herhangi bir tedavi almayan 34 olgu çalışmaya dahil edildi. Hastaların kayıtları retrospektif olarak incelendi. Tüm hastaların Snellen eşeline göre düzeltilmiş en iyi görme keskinlikleri, ön segment biomikroskopisi ve fundus muayeneleri, optik koherens tomografi ve fundus floresan anjiyografi tetkikleri kaydedildi. Kayıtlar SPSS 14,0 programı kullanılarak istatistiksel olarak değerlendirildi. Hastaların yaş ortalaması 33,17±6,13, cinsiyetleri ise 26 erkek ve 8 bayandı. Olguların %58,8’inde A tipi kişilik mevcuttu. Hastalık başlamadan önce ciddi stres bozukluğu yaşayan hastaların oranı ise %82,4(28)’ dür. Olguların mesleklere göre dağılımı ise %35,3 askeri personel, %20,6 polis, %2,9 doktor, %11,8 esnaf, %23,5 işçi, %5,9 ev hanımı olarak bulunmuştur. İlk başvuruda yapılan muayenede SSR gelişen gözdeki Snellen eşeline göre en iyi düzeltilmiş görme keskinliği ortalama 0,59±2,04’dür. Hastalığın gözlere göre dağılım oranı ise; %73,6 sağ göz, %23,5 sol göz ve %2,9 her iki göz olarak ortaya çıkmıştır. Hastalığın altı aylık takipten sonra kronikleşme oranı %14,7’dir. Kronikleşmeyen olguların ortalama iyileşme süreleri 1,90±0,63 aydır. SSR’de stres en önemli predispozan faktördür. Strese bağlı ortaya çıkan bazı biyokimyasal değişiklikler koroid damarlarında permeabilite değişikliği yapmaktadır. Hastalığın doğal seyrinde büyük bir kısmı spontan olarak iyileşmektedir. Kronik ve tekrarlayan olgularda tedavide bu patofizyolojik mekanizma düşünülerek ileri çalışmaların yapılması gerekmektedir. 

References

  • Bouzas, E.A., Karadimas, P., Pournaras, C.J., 2002. Central serous chorioretinopathy and glucocorticoids. Surv. Ophthalmol. 47, 431-438.
  • Burumcek, E., Mudun, A., Karakocoglu, S., Arslan, M.O., 1997. Laser photocoagulation for persistent central serous retinopathy: results of long term follow-up. Ophthalmology. 104, 616-622.
  • Cardillo Piccolino, F., Eandi, C.M., Ventre, L., Rigault de la Longrais, R.C., Grignolo, F.M., 2003. Photodynamic therapy for chronic central serous chorioretinopathy. Retina. 23, 752-763.
  • Castro-Correia, J., Coutinho, M.F., Rosas, V., Maia, J., 1992. Long-term follow-up of central serous retinopathy in 150 patients. Doc. Ophthalmol. 81, 379-386.
  • Chrousos, G.P., Gold, P.W., 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267, 1244-1252.
  • Costa, R.A., Calucci, D., Skaf, M., Cardillo, J.A., Castro, J.C., Melo, L.A.Jr, Martins, M.C., Kaiser, P.K., 2004. Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest. Ophthalmol. Vis. Sci. 45, 2399-2406.
  • Ficker, L., Vafidis, G., While, A., Leaver, P., 1988. Long-term follow up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br. J. Ophthalmol. 72, 829-834.
  • Friedman, M., Byers, S.O., Rosenman, R.H., Franklin, R. E., 1970. Coronary-prone individuals (Type-A behavior pattern). Some biochemical characteristics. JAMA. 212, 1030-1037.
  • Gass, J.D.M., 1977. Photocoagulation treatment of idiopathic central serous chorioretinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 83, 456-467.
  • Gonzalez, C., 1992. Decollements sereux retiniens. J. Fr. Ophthalmol. 15, 529-536. Harrington, D.O., 1948. Psychosomatic interrelationship inophthalmology. Am. J. Ophthalmol. 31, 1241-1251.
  • Hee, M.R., Puliafito, C.A., Wong, C., 1995. Optical coherence tomography of central serous chorioretinopathy. Am. J. Ophthalmol. 120, 65- 74.
  • Huang, W.C., Chen, W.L., Tsai, Y.Y., Chiang, C.C., Lin, J.M., 2009. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eye. 23, 488-489.
  • Maumenee, A.E., 1965. Macular diseases: clinical manifestations. Trans. Am. Acad. Ophthalmol. 69, 605-613.
  • Meyerle, C.B., Freund, K.B., Bhatnagar, P., Shah, V., Yannuzzi, L.A., 2007. Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina, 27, 943-946.
  • Nagayoski, K., 1971. Experimental study of chorioretinopathy by intravenous injection of adrenaline. Acta Soc. Ophthalmol. Jpn. 75, 1720- 1727.
  • Polak, B.C.P., Baarsma, G.S., Snyers, B., 1995. Diffuse retinal pigment epithelyopathy complicating systemic corticosteroid treatment. Br. J. Ophthalmol. 79, 922-925.
  • Pomerleau, O.F., Pomerleau, C.S., 1990. Cortisol response to a psychological stressor and/or nicotine. Pharmacol. Biochem. Behav. 36, 211- 213.
  • Prunte, C., Flammer, J., 1996. Choroidal capillary and venous congestion in central serous choroidopathy. Am. J. Ophthalmol. 121, 26-34.
  • Quillen, D.A., Gass, D.M., Brod, R.D., Gardner, T.W., Blankenship, G.W., Gottlieb, J.L., 1996. Central serous chorioretinopathy in women. Ophthalmology. 103, 72-79.
  • Robertson, D.M., illstrupp, D., 1983. Direct, indirect and sham laser treatment in the management of central serous choroidopathy. Am. J. Ophthalmol. 95, 457-466.
  • Shukla, D., Kolluru, C., Vignesh, T.P., Karthikprakash, S., Kim, R., 2006. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy. Eye. 22, 100-106.
  • Spahn, C., Wiek, J., Burger, T., Hansen, L., 2003. Psychosomatic aspects in patients with central cerous chorioretinopathy. Br. J. Ophthalmol. 87, 704-708.
  • Von Graefe, A., 1866. Kurzere abhandlungen, notizen und casaistische mitheilugnen vermischten inhalts: VI. Ueber zentrale recidivirende retinitis. Graefes Arch. Clin. Ophthalmol. 12, 211-215.
  • Yannuzzi, L.A., 1986. Type A behavior and central serous chorioretinopathy. Trans. Am. Ophthalmol. Soc. 84, 799-845.
  • Yannuzzi, L.A., Slakter, J.S., Kaufman, S.R., Gupta, K., 1992. Laser treatment of diffuse retinal pigment epitheliopathy. Eur. J. Ophthalmol. 2, 103-114.
  • Yanoff, M., Duker, J.S., 2004. Ophtalmology: 2nd edition, St. Louis: Mosby, p.p. 938-941.
  • Zeligs, M.A., 1947. Central angiospastic retinopathy: a psychosomatic study of the occurrence in military personnel. Psychosom. Med. 9, 110- 117.
There are 27 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Surgery Medical Sciences
Authors

Yıldıray Yıldırım This is me

Fahrettin Akay

Publication Date December 27, 2012
Submission Date March 14, 2012
Published in Issue Year 2012 Volume: 29 Issue: 4

Cite

APA Yıldırım, Y., & Akay, F. (2012). Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri. Journal of Experimental and Clinical Medicine, 29(4), 272-275. https://doi.org/10.5835/jecm.omu.29.04.004
AMA Yıldırım Y, Akay F. Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri. J. Exp. Clin. Med. December 2012;29(4):272-275. doi:10.5835/jecm.omu.29.04.004
Chicago Yıldırım, Yıldıray, and Fahrettin Akay. “Santral seröz Koryoretinopatide Predispozan faktörler Ve hastalığın doğal Seyri”. Journal of Experimental and Clinical Medicine 29, no. 4 (December 2012): 272-75. https://doi.org/10.5835/jecm.omu.29.04.004.
EndNote Yıldırım Y, Akay F (December 1, 2012) Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri. Journal of Experimental and Clinical Medicine 29 4 272–275.
IEEE Y. Yıldırım and F. Akay, “Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri”, J. Exp. Clin. Med., vol. 29, no. 4, pp. 272–275, 2012, doi: 10.5835/jecm.omu.29.04.004.
ISNAD Yıldırım, Yıldıray - Akay, Fahrettin. “Santral seröz Koryoretinopatide Predispozan faktörler Ve hastalığın doğal Seyri”. Journal of Experimental and Clinical Medicine 29/4 (December 2012), 272-275. https://doi.org/10.5835/jecm.omu.29.04.004.
JAMA Yıldırım Y, Akay F. Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri. J. Exp. Clin. Med. 2012;29:272–275.
MLA Yıldırım, Yıldıray and Fahrettin Akay. “Santral seröz Koryoretinopatide Predispozan faktörler Ve hastalığın doğal Seyri”. Journal of Experimental and Clinical Medicine, vol. 29, no. 4, 2012, pp. 272-5, doi:10.5835/jecm.omu.29.04.004.
Vancouver Yıldırım Y, Akay F. Santral seröz koryoretinopatide predispozan faktörler ve hastalığın doğal seyri. J. Exp. Clin. Med. 2012;29(4):272-5.